1. Indications & Usage

Sunixar 12.5mg Capsules are indicated primarily under strict professional medical, clinical research, and specialist oncology supervision for:

• Advanced Renal Cell Carcinoma (RCC): Prescribed for the systemic treatment of advanced or metastatic renal cell carcinoma.

• Gastrointestinal Stromal Tumor (GIST): Indicated for the treatment of gastrointestinal stromal tumors after disease progression on or intolerance to imatinib mesylate.

• Pancreatic Neuroendocrine Tumors (pNET): Administered for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease

2. Mechanism of Action: Multi-Kinase & Angiogenesis Inhibition

Sunitinib stops oncogenic cellular duplication and vascular blood supply tracking through precise target receptor blockade:

• Simultaneous RTK Inhibition: Sunixar targets and binds to multiple receptor tyrosine kinases, specifically blocking vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3) and platelet-derived growth factor receptors (PDGFR-$\alpha$, PDGFR-$\beta$).

• Angiogenesis Arrest: By shutting down downstream VEGFR signaling pathways within endothelial cells, it starves the tumor matrix of essential oxygen and blood capillary growth.

• Tumor Microenvironment Disruption: It targets KIT (CD117), FLT3, and RET signaling lines, permanently interrupting intracellular proliferation cascades and inducing tumor cell apoptosis.

3. Storage, Stability & Commercial Packaging Specifications

• Temperature Maintenance: Store in a dry, cool environment below 30°C. Protect shipments from prolonged thermal spikes, moisture vapor transmission, and direct ambient ultraviolet sunlight.

• Commercial Integrity: Packed in standard high-density polyethylene (HDPE) bottles containing specialized desiccant inserts or heavy-duty foil blister setups designed to withstand long-range transit variables.

• Safety Protocol: Keep strictly out of the sight and reach of children.

4. Safety Profile, Side Effects, and Clinical Monitoring

Because Sunixar is a highly potent antineoplastic agent, ongoing specialist clinical monitoring is mandatory to protect patient safety.

• Common Manifestations: Fatigue, diarrhea, nausea, stomatitis, dyspepsia, hypertension, and hand-foot syndrome (palmar-plantar erythrodysesthesia).

• Cardiovascular & Hematological Monitoring: Regular evaluation of left ventricular ejection fraction (LVEF) and blood pressure metrics is strongly advised. Routine complete blood counts (CBC) are required due to potential myelosuppression (neutropenia, thrombocytopenia).

• Hepatic Supervision: Periodic liver function profiles (ALT/AST/Bilirubin) must be carried out to safeguard against drug-induced hepatotoxicity.

5. Regulatory and Compliance Documentation

ERNEST IMPEX ensures that every trade lane shipment of Sunixar 12.5mg complies with strict international customs and medical export expectations by providing:

• Comprehensive Commercial Invoice & Itemized Packing Lists

• Validated Certificates of Analysis (CoA) from approved laboratories

• Legalized Export Documentation (IEC & Custom shipping clearance data)

• Secure, temperature-shielded freight layout for air or cargo routing

💡 Why Choose ERNEST IMPEX?

• Direct sourcing channels from verified manufacturing infrastructure in India

• Scale-ready capacity for hospital groups, clinical distributors, and regional wholesalers

• Precision documentation routing for transparent customs tracking

• Dedicated global trade desks providing end-to-end support

PRESCRIPTION MEDICINE: YES

Sunixar 12.5mg Capsules must be supplied and administered strictly under the authority of a registered professional. The clinical and pharmacological data listed here serves strictly as a commercial guide for international bulk procurement, regulatory compliance matching, and wholesale trade awareness

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Official Websites:

www.ernestimpex.com
www.oncologymedicinesupplier.com
www.ernestpharmaceuticals.com
www.ernestvision.com

📧 Corporate Email : exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
📲 WhatsApp Link https://wa.me/919359902383